Combined Pre-operative Treatment for Cataracts
Trial Summary
What is the purpose of this trial?
This is a multicenter, 2-arm, randomized, prospective study of patients slated for bilateral cataract extraction. One eye will be randomized to the Study Arm, and the fellow eye will be randomized to the Control Arm.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes those taking oral anti-inflammatory medications for systemic diseases, except for low-dose aspirin and ibuprofen for headaches.
Is triamcinolone acetonide generally safe for humans?
Research Team
Paul Singh, MD
Principal Investigator
The Eye Centers of Racine & Kenosha
Eligibility Criteria
This trial is for patients scheduled for cataract surgery in both eyes. It's not clear what the specific inclusion or exclusion criteria are, but typically participants would need to be adults with a diagnosis of cataracts and no other major eye diseases.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative
Participants self-administer ketorolac and moxifloxacin drops before surgery
Surgery and Immediate Post-operative
Participants receive in-office drops and undergo cataract surgery
Post-operative Treatment
Participants self-administer ketorolac, prednisolone acetate, and moxifloxacin drops
Follow-up
Participants are monitored for inflammation and other outcomes
Treatment Details
Interventions
- Triamcinolone Acetonide
Find a Clinic Near You
Who Is Running the Clinical Trial?
Inder Paul Singh, M.D.
Lead Sponsor
The Eye Associates
Collaborator